YU47700B - Interferoni i postupak za njihovo dobivanje - Google Patents

Interferoni i postupak za njihovo dobivanje

Info

Publication number
YU47700B
YU47700B YU162281A YU162281A YU47700B YU 47700 B YU47700 B YU 47700B YU 162281 A YU162281 A YU 162281A YU 162281 A YU162281 A YU 162281A YU 47700 B YU47700 B YU 47700B
Authority
YU
Yugoslavia
Prior art keywords
leukocyte interferon
mature human
human leukocyte
producing
dna strand
Prior art date
Application number
YU162281A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU162281A (en
Inventor
D.V.N. Goeddel
S. Pestka
Original Assignee
F. Hoffmann-La Roche & Co. Ag.
Genen-Tech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27496622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU47700(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/256,204 external-priority patent/US6610830B1/en
Application filed by F. Hoffmann-La Roche & Co. Ag., Genen-Tech, Inc. filed Critical F. Hoffmann-La Roche & Co. Ag.
Priority to SI8111622A priority Critical patent/SI8111622B/sl
Publication of YU162281A publication Critical patent/YU162281A/xx
Priority to HRP-1622/81A priority patent/HRP930291A2/xx
Publication of YU47700B publication Critical patent/YU47700B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
YU162281A 1980-07-01 1981-06-30 Interferoni i postupak za njihovo dobivanje YU47700B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI8111622A SI8111622B (sl) 1980-07-01 1981-06-30 Interferoni in postopek za njihovo pridobivanje
HRP-1622/81A HRP930291A2 (en) 1980-07-01 1993-03-10 Interferones and process for the preparation thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16498680A 1980-07-01 1980-07-01
US18490980A 1980-09-08 1980-09-08
US20557880A 1980-11-10 1980-11-10
US06/256,204 US6610830B1 (en) 1980-07-01 1981-04-21 Microbial production of mature human leukocyte interferons

Publications (2)

Publication Number Publication Date
YU162281A YU162281A (en) 1984-02-29
YU47700B true YU47700B (sh) 1996-01-08

Family

ID=27496622

Family Applications (1)

Application Number Title Priority Date Filing Date
YU162281A YU47700B (sh) 1980-07-01 1981-06-30 Interferoni i postupak za njihovo dobivanje

Country Status (36)

Country Link
EP (2) EP0211148B2 (de)
AR (1) AR242833A1 (de)
AT (3) ATE79901T1 (de)
AU (1) AU552004B2 (de)
BG (1) BG42189A3 (de)
BR (1) BR8104189A (de)
CH (2) CH651308A5 (de)
CS (1) CS273152B2 (de)
DD (3) DD210305A5 (de)
DE (3) DE3125706C2 (de)
DK (1) DK173543B1 (de)
DZ (1) DZ312A1 (de)
ES (1) ES8207514A1 (de)
FI (1) FI82712C (de)
FR (1) FR2486098B1 (de)
GB (1) GB2079291B (de)
GE (1) GEP19960519B (de)
GR (1) GR75714B (de)
HK (1) HK49285A (de)
HU (1) HU196457B (de)
IE (1) IE49255B1 (de)
IT (1) IT1137272B (de)
KE (1) KE3534A (de)
LU (1) LU83461A1 (de)
MC (1) MC1396A1 (de)
MY (1) MY8700711A (de)
NL (1) NL8103151A (de)
NO (1) NO159392C (de)
NZ (1) NZ197572A (de)
PH (1) PH18036A (de)
PL (3) PL148260B1 (de)
PT (1) PT73289B (de)
RO (1) RO87590A (de)
SE (2) SE465223C5 (de)
SU (1) SU1414319A3 (de)
YU (1) YU47700B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
DK170476B1 (da) 1980-04-03 1995-09-11 Biogen Inc Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
EP0085693A1 (de) * 1981-08-14 1983-08-17 A/S Alfred Benzon Gegenstände betreffend menschliche interferon-alpha-subtyp-eiweissstoffe sowie übereinstimmende antikörper
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US4973479A (en) * 1982-01-15 1990-11-27 Cetus Corporation Interferon-α61
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
US4975276A (en) * 1982-01-15 1990-12-04 Cetus Corporation Interferon-alpha 54
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
EP0088994B1 (de) * 1982-03-15 1991-06-19 Schering Corporation Hybride DNS, damit hergestellte Bindungszusammensetzung und Verfahren dafür
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
US4748233A (en) * 1982-03-23 1988-05-31 Bristol-Myers Company Alpha-interferon Gx-1
US4695543A (en) * 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
JPS60500574A (ja) * 1983-02-24 1985-04-25 インステイチユト　オルガニチエスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスア−ル ヒト白血球インタ−フェロンｎ及び細菌細胞におけるその製造方法
EP0165942A1 (de) * 1983-12-23 1986-01-02 Monash University Herstellung menschlichen g(a)-interferons
SU1364343A1 (ru) * 1984-07-13 1988-01-07 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Способ получени человеческого лейкоцитарного интерферона альфа-2
WO1986002068A1 (fr) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Separation mutuelle de proteines
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
JP2514950B2 (ja) * 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
CA1309044C (en) * 1987-11-09 1992-10-20 Toshiya Takano Method of producing foreign gene products
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
WO1991003251A1 (en) * 1989-09-08 1991-03-21 California Institute Of Biological Research Cr2 ligand compositions and methods for modulating immune cell functions
DE3932311A1 (de) * 1989-09-28 1991-04-11 Boehringer Ingelheim Int Verfahren zur reinigung von beta-interferon
PT741577E (pt) * 1994-03-07 2003-03-31 Imperial College Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
EP1104809A1 (de) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von Alpha-Interferon
GB9609932D0 (en) * 1996-05-13 1996-07-17 Hoffmann La Roche Use of IL-12 and IFN alpha for the treatment of infectious diseases
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
CA2311681A1 (en) 1997-12-08 1999-06-17 Genentech, Inc. Human interferon-epsilon: a type i interferon
ATE298251T1 (de) 1998-08-06 2005-07-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
EP1355939A2 (de) * 2000-11-03 2003-10-29 Pestka Biomedical Laboratories, Inc. Interferone, deren verwendungen und zusammensetzungen
FR2822845B1 (fr) 2001-03-30 2003-12-12 Genodyssee Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
KR20080009111A (ko) 2005-04-11 2008-01-24 새비언트 파마수티컬즈 인크. 유레이트 옥시다아제의 변이형 및 이의 용도
CN101918430A (zh) * 2008-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 非糖基化蛋白质的纯化
JP2012531596A (ja) 2009-06-25 2012-12-10 サヴィエント・ファーマシューティカルズ・インコーポレイテッド Ｐｅｇ化ウリカーゼ療法における血清尿酸をモニタリングすることにより注入反応の危険性および抗体媒介性効果消失を予測するための方法およびキット
CN116637177A (zh) 2016-11-11 2023-08-25 好利恩治疗美国公司 泼尼松和尿酸酶分子的组合疗法及其用途
WO2018087345A1 (en) 2016-11-14 2018-05-17 F. Hoffmann-La Roche Ag COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (de) * 1978-11-24 1982-12-04 Hoffmann La Roche
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.

Also Published As

Publication number Publication date
SU1414319A3 (ru) 1988-07-30
EP0043980A3 (en) 1982-09-15
FI82712C (fi) 1991-04-10
ATE79901T1 (de) 1992-09-15
CS503781A2 (en) 1990-07-12
PL148261B1 (en) 1989-09-30
EP0043980B1 (de) 1987-09-16
DD210304A5 (de) 1984-06-06
NO159392C (no) 1988-12-21
DE3177288T3 (de) 2000-03-16
IT1137272B (it) 1986-09-03
HU196457B (en) 1988-11-28
FR2486098B1 (fr) 1985-12-27
EP0211148B1 (de) 1992-08-26
ES503528A0 (es) 1982-10-01
PL148276B1 (en) 1989-09-30
DE3125706A1 (de) 1982-04-15
IE49255B1 (en) 1985-09-04
IT8122682A0 (it) 1981-07-01
BR8104189A (pt) 1982-03-16
LU83461A1 (de) 1983-04-06
DD210305A5 (de) 1984-06-06
FI812067L (fi) 1982-01-02
FI82712B (fi) 1990-12-31
SE465223C5 (sv) 1998-02-10
AU7246281A (en) 1982-01-07
ES8207514A1 (es) 1982-10-01
EP0043980A2 (de) 1982-01-20
NZ197572A (en) 1985-07-31
GR75714B (de) 1984-08-02
DZ312A1 (fr) 2004-09-13
DE3125706C2 (de) 1995-05-24
DK173543B1 (da) 2001-02-05
NO812247L (no) 1982-01-04
CH657141A5 (de) 1986-08-15
NO159392B (no) 1988-09-12
CH651308A5 (de) 1985-09-13
PL231940A1 (en) 1983-07-18
GB2079291A (en) 1982-01-20
ATA290981A (de) 1985-09-15
BG42189A3 (en) 1987-10-15
PL148260B1 (en) 1989-09-30
DD202307A5 (de) 1983-09-07
AU552004B2 (en) 1986-05-22
FR2486098A1 (fr) 1982-01-08
EP0211148A1 (de) 1987-02-25
RO87590A (ro) 1986-07-30
GEP19960519B (en) 1996-07-02
AR242833A1 (es) 1993-05-31
CS273152B2 (en) 1991-03-12
MY8700711A (en) 1987-12-31
DE3177288T2 (de) 1992-12-10
SE465223B (sv) 1991-08-12
ATE29727T1 (de) 1987-10-15
YU162281A (en) 1984-02-29
HK49285A (en) 1985-07-05
GB2079291B (en) 1984-06-13
PT73289A (en) 1981-07-01
KE3534A (en) 1985-06-07
PH18036A (en) 1985-03-06
EP0211148B2 (de) 1999-11-24
DK291081A (da) 1982-01-02
DE3176448D1 (en) 1987-10-22
AT380272B (de) 1986-05-12
SE8104093L (sv) 1982-01-02
MC1396A1 (fr) 1982-04-27
NL8103151A (nl) 1982-02-01
PT73289B (en) 1983-05-11
DE3177288D1 (de) 1992-10-01
IE811463L (en) 1982-01-01

Similar Documents

Publication Publication Date Title
YU46597B (sh) Postupak za proizvodnju hibridni interferoni humanih leukocita
BR8206068A (pt) Composicoes de materia,polipeptideo,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,extrato de cultura celular,cultura de celulas transformantes,uso de interferon imune humano maduro,processo de expressao de um gene,processo para producao de um polipeptideo,processo para producao de um veiculo de expressao,e produto obtido por tais processos
ES8307297A1 (es) Proceso para la produccion microbiana de interferon fibro- blasto humano
EP0237545A4 (de) Herstellung von pluripotenten granulozytkolonie erregendem faktor.
IL80022A (en) Cloned human basic fibroblast growth factor, methods for its preparation, compositions containing it, dna sequences encoding therefor and vectors and host cells containing said dna
GEP19960519B (en) Method of producing human luecocytary interferons
ES8606489A1 (es) Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura
ATE318917T1 (de) Verfahren zur bakteriellen herstellung von heterologen polypeptiden mit disulfidbrücke
CN117736305B (zh) 一种新的i型重组胶原蛋白、其生产方法及用途
PT666914E (pt) Nova proteina ligando da selectina p
EP0035781A3 (de) Mikrobiologische Synthese von beta-Endorphin
ES8500327A1 (es) Procedimiento para producir polipeptido
KR840008697A (ko) 상동 효모 신호를 이용한 이종단백질의 합성, 분비 및 표현매개체 제조방법
MX9203645A (es) Nuevos interferones de humano y proceso biotecnologico para su produccion.
DE3175357D1 (en) Dna sequences encoding various allelic forms of mature thaumatin, recombinant plasmids comprising said dna's and a process for their preparation, bacterial cultures comprising said recombinant plasmids, and method for producing mature thaumatin
ES2059854T3 (es) Nuevo polipeptido y su produccion.
ATE30246T1 (de) Verfahren zur herstellung reifer proteine aus schmelzproteinen hergestellt in pro- oder eukaryotischen zellen.
EP0072541A3 (de) Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
EP0171000A3 (de) Verfahren zur Herstellung eines heterologen, reifen Proteins oder Peptids
DE68920321D1 (de) Verfahren zur herstellung eines menschlichen "neutrophil chemotactic factor"-polypeptids.
Stadler et al. Biological and biochemical characteristics of the basophil-like cell promoting activity (BaPA) and a human IL 3-like activity
SI8111622B (sl) Interferoni in postopek za njihovo pridobivanje
Heil et al. Production and response to an autologous growth factor isolated from human leukemia cells
Volfova et al. Utilization of methanol in biotechnology.